Participants 94 140 5
patients with advanced head and neck carcinoma
Participants 354 442 6
patients with advanced head and neck squamous cell carcinoma or nasopharyngeal carcinoma
Participants 444 597 6
Patients with locally advanced or metastatic head and neck squamous cell carcinoma or nasopharyngeal carcinoma not suitable for operation or radiotherapy
Participants 730 797 6
One hundred and thirty-six eligible patients were randomly assigned
Participants 1566 1654 4
patients with advanced head and neck squamous cell carcinoma or nasopharyngeal carcinoma
